💊FDA PHARMA today 💊FDA PHARMA to Thursday December 14th, 2017By Tokio X'press FDA, Pharmaceutical Bristol-Myers Squibb, Pfizer, Bayer
👾Japan Ministry of Health, Labor and Welfare Approves Opdivo (nivolumab) for the Treatment of Patients with Unresectable Advanced or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy 👾Japan Ministry of Hea Saturday September 23rd, 2017By Tokio X'press JPN, Pharmaceutical, USA Bristol-Myers Squibb
